Hemangi B. Shah
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Hemangi B. Shah has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Mark L. Lang
Department of Microbiology and Immunology, University of Oklahoma Health Sciences, Oklahoma City, OK 73104, USA
2 shared publications Carol F. Webb
Department of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States
1 shared publicationEdgar J. Scott
Department of Microbiology and Immunology, University of Oklahoma Health Sciences Center (OUHSC)
1 shared publication- Jason L. Larabee
Department of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA
1 shared publication Jimmy D. Ballard
Department of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States
1 shared publication- Jimmy D. Ballard
University of Oklahoma Health Sciences Center
1 shared publication
Latest Publications
- Open Access
- 20 August 2020
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 5 (16)
Human C. difficile toxin–specific memory B cell repertoires encode poorly neutralizing antibodies
Clostridioides difficile is a leading cause of nosocomial infection responsible for significant morbidity and mortality with limited options for therapy. Secreted C . difficile toxin B (TcdB) is a major contributor to disease pathology, and select TcdB-specific Abs may protect against disease recurrence. However, the high frequency of recurrence suggests that the memory B cell response, essential for new Ab production following C . difficile reexposure, is insufficient. We therefore isolated TcdB-specific memory B cells from individuals with a history of C . difficile infection and performed single-cell deep sequencing of their Ab genes. Herein, we report that TcdB-specific memory B cell–encoded antibodies showed somatic hypermutation but displayed limited isotype class switch. Memory B cell–encoded mAb generated from the gene sequences revealed low to moderate affinity for TcdB and a limited ability to neutralize TcdB. These findings indicate that memory B cells are an important factor in C . difficile disease recurrence.
- 20 August 2020
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 5 (16)
Open AccessHuman C. difficile toxin–specific memory B cell repertoires encode poorly neutralizing antibodies
Clostridioides difficile is a leading cause of nosocomial infection responsible for significant morbidity and mortality with limited options for therapy. Secreted C . difficile toxin B (TcdB) is a major contributor to disease pathology, and select TcdB-specific Abs may protect against disease recurrence. However, the high frequency of recurrence suggests that the memory B cell response, essential for new Ab production following C . difficile reexposure, is insufficient. We therefore isolated TcdB-specific memory B cells from individuals with a history of C . difficile infection and performed single-cell deep sequencing of their Ab genes. Herein, we report that TcdB-specific memory B cell–encoded antibodies showed somatic hypermutation but displayed limited isotype class switch. Memory B cell–encoded mAb generated from the gene sequences revealed low to moderate affinity for TcdB and a limited ability to neutralize TcdB. These findings indicate that memory B cells are an important factor in C . difficile disease recurrence.
- Open Access
- 15 January 2019
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 9, 3064
Insights From Analysis of Human Antigen-Specific Memory B Cell Repertoires
Memory B cells that are generated during an infection or following vaccination act as sentinels to guard against future infections. Upon repeat antigen exposure memory B cells differentiate into new antibody-secreting plasma cells to provide rapid and sustained protection. Some pathogens evade or suppress the humoral immune system, or induce memory B cells with a diminished ability to differentiate into new plasma cells. This leaves the host vulnerable to chronic or recurrent infections. Single cell approaches coupled with next generation antibody gene sequencing facilitate a detailed analysis of the pathogen-specific memory B cell repertoire. Monoclonal antibodies that are generated from antibody gene sequences allow a functional analysis of the repertoire. This review discusses what has been learned thus far from analysis of diverse pathogen-specific memory B cell compartments and describes major differences in their repertoires. Such information may illuminate ways to advance the goal of improving vaccine and therapeutic antibody design.
- 15 January 2019
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 9, 3064
Open AccessInsights From Analysis of Human Antigen-Specific Memory B Cell Repertoires
Memory B cells that are generated during an infection or following vaccination act as sentinels to guard against future infections. Upon repeat antigen exposure memory B cells differentiate into new antibody-secreting plasma cells to provide rapid and sustained protection. Some pathogens evade or suppress the humoral immune system, or induce memory B cells with a diminished ability to differentiate into new plasma cells. This leaves the host vulnerable to chronic or recurrent infections. Single cell approaches coupled with next generation antibody gene sequencing facilitate a detailed analysis of the pathogen-specific memory B cell repertoire. Monoclonal antibodies that are generated from antibody gene sequences allow a functional analysis of the repertoire. This review discusses what has been learned thus far from analysis of diverse pathogen-specific memory B cell compartments and describes major differences in their repertoires. Such information may illuminate ways to advance the goal of improving vaccine and therapeutic antibody design.